Get started
Author

Anna L. Neverova

Observed names: A L Neverova, A. L. Neverova, Anna Leonidovna Neverova, А. Л. Неверова, А.Л. Неверова, Анна Леонидовна Неверова, Неверова А.Л., Неверова Анна Леонидовна
Institution: Botkin Hospital
ORCID: 0000-0001-9524-7070
Observed ORCID: 0000-0001-9524-7070
OpenAlex ID: A5085541587
[Incidence of chronic myeloid leukemia in 6 regions of Russia according to the data of the 2009-2012 population-based study].
2014 · S M Kulikov, O Iu Vinogradova, et al. · PubMed · 11
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study
2023 · O. Yu. Vinogradova, D. I. Shikhbabaeva, et al. · Oncohematology · 4
PDF
Multiaberrant cells in groups of people exposed to radiation in different situations and their possible biological role
2010 · E. A. Aseeva, G. P. Snigiryova, et al. · BIOPHYSICS · 4
[The multiabberant cells in groups of people exposed to radiation due to different situations and their possible biological part].
2009 · E A Aseeva, G P Snigireva, et al. · PubMed · 4
Postmitotic reconstruction of nucleoli in culture cells with UV-microbeam photoinactivated centrosome.
1999 · A L Neverova, R E Uzbekov, et al. · PubMed · 4
Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response
2023 · O. Yu. Vinogradova, M. M. Pankrashkina, et al. · Clinical oncohematology · 3
PDF
Characteristics of regional epidemiological indicators of chronic myeloproliferative neoplasms
2025 · O. Yu. Vinogradova, A. L. Neverova, et al. · Oncohematology · 2
PDF
Possibilities of targeted therapy for myelofibrosis: Moscow experience
2022 · O. Yu. Vinogradova, M. M. Pankrashkina, et al. · Oncohematology · 2
PDF
Influence of different chromosomal abnormalities in Ph-positive bone marrow cells on the chronic myeloid leukemia course during tyrosine kinase inhibitors therapy
2014 · O. Yu. Vinogradova, E. A. Aseeva, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2
[The effect of ultraviolet microbeam irradiation of the centrosome on cellular behavior. IV. Synthetic activity, cell spreading and growth with an inactivated centrosome].
1996 · A L Neverova, R E Uzbekov, et al. · PubMed · 2
Treatment opportunities for refractory immune thrombocytopenia
2024 · M. M. Pankraskina, O. Yu. Vinogradova, et al. · MD-Onco · 1
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study
2024 · O. Yu. Vinogradova, M. M. Pankraskina, et al. · Oncohematology · 1
PDF
Long-term dynamics of epidemiological characteristics of some chronic leukemia and lymphoma in Moscow before, during and after the pandemic of the new coronavirus infection COVID-19. Epidemiologic study
2024 · Olga Yu. Vinogradova, Mikhail V. Chernikov, et al. · Journal of Modern Oncology · 1
PDF
Targeted therapy for advanced forms of systemic mastocytosis in real clinical practice
2023 · D. I. Shikhbabaeva, O. Yu. Vinogradova, et al. · Oncohematology · 1
PDF
New type of cells with multiple chromosome rearrangements
2009 · Elena A. Aseeva, Galina P. Snigiryova, et al. · Applied Radiation and Isotopes · 1
Genetic landscape of patients at diagnosis of chronic myeloid leukemia in the chronic phase: association with targeted therapy efficacy
2026 · O. Yu. Vinogradova, A. L. Neverova, et al. · Oncohematology
Применение агонистов рецептора тромбопоэтина при резистентных формах иммунной тромбоцитопении
2026 · М.М. Панкрашкина, О.Ю. Виноградова, et al. · Тромбоз гемостаз и реология
Biosimilar of the monoclonal antibody immunoglobulin G1κ daratumumab in treatment regimens for multiple myeloma patients
2026 · M. M. Pankrashkina, A. L. Neverova, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
PDF
Genetic features of indolent and advanced forms of systemic mastocytosis
2025 · D. I. Shikhbabaeva, O. Yu. Vinogradova, et al. · Oncohematology
PDF
Primary and secondary myelofibrosis: ophthalmological manifestations at onset and during therapy
2025 · O. Yu. Vinogradova, L. B. Egoryan, et al. · Oncohematology
Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
2024 · O. Yu. Vinogradova, M. M. Pankrashkina, et al. · Oncohematology
PDF
Лейкозы и миелодиспластические синдромы, возникшие после проведения противоопухолевой терапии: результаты 16-летних наблюдений
2011 · Domracheva Ev, Е. А. Асеева, et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Клональные хромосомные аномалии в Ph-негативных клетках у больных хроническим миелолейкозом, получающих терапию ингибиторами тирозинкиназ
2010 · Olga Vinogradova, Е. А. Асеева, et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика
[Study of the time course of mixed chimerism by fluorescent in situ hybridization in patients with chronic myeloid leukemia after allogenic transplantation of bone marrow].
2001 · O A Vinogradova, V G Savchenko, et al. · PubMed
Первичный, постполицитемический, посттромбоцитемический миелофиброз: офтальмологические проявления в дебюте и в процессе терапии
· О. Ю. Виноградова, Л. Б. Егорян, et al. · CyberLeninK (CyberLeninka)
Works count: 33
Citation count: 43
H-index: 4
I10-index: 1
Year
Topic
Type